comparemela.com

Latest Breaking News On - Glenmark ryaltris - Page 1 : comparemela.com

Inhaler sales hit new high in January as India struggles to breathe

Combination Product for Symptoms of Seasonal Allergic Rhinitis Approved by US FDA

Combination Product for Symptoms of Seasonal Allergic Rhinitis Approved by US FDA

New Combination Product for Symptoms of Seasonal Allergic Rhinitis Approved by US FDA with Aptar Pharma s VP3 Nasal Spray System

New Combination Product for Symptoms of Seasonal Allergic Rhinitis Approved by US FDA with Aptar Pharma’s VP3 Nasal Spray SystemCrystal Lake, Illinois, January 27, 2022 - Aptar Pharma, a global leader in drug delivery systems, services and active material science solutions, today announced that its VP3 multido.

Glenmark Pharma launches nasal spray Ryaltris in India

Glenmark Pharma launches nasal spray Ryaltris in India SECTIONS Last Updated: May 03, 2021, 11:25 AM IST Share Synopsis Glenmark being one of the leaders in respiratory segment, has been the first to launch the branded generic version at an affordable cost for the treatment of allergic rhinitis in India. Agencies Glenmark Pharma on Monday announced of launch its nasal spray Ryaltris, used for treatment of moderate to severe allergic rhinitis, in India. Glenmark being one of the leaders in respiratory segment, has been the first to launch the branded generic version at an affordable cost for the treatment of allergic rhinitis in India. This will provide patients a far more convenient, cost effective treatment option in the country, Glenmark said in a regulatory filing.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.